reports
- Nitin Agarwal
Management Speak: Hikal (Unrated) - At an Inflection point
Hikal is a unique business model with strong presence across pharmaceutical (pharma) and agrochemicals (agchem) sectors, further diversified across Custom Synthesis (CS) and generic API. While CS has been a primary driver in the agchem segment, pharma has been largely driven by generic APIs. Hikal has seen steady recovery over FY14-18 post muted FY09-13 with FY18 marking an inflection point having reported 28%/13% Revenue/PAT growth, respectively. Strong R&D capabilities coupled with investments...
Ford Equity International Rating and Forecast Report
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.